Anika Therapeutics
ANIKAlgoritmens signaler
- ›Starkt 3m-momentum (+54.9%)
- ›Starkt 6m-momentum (+110.7%)
- ›Starkt 12m-momentum (+119.8%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (41% årlig)
- ›+143% från 52v-botten
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsAnika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance - Yahoo Finance
15 h sedanAnika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance Yahoo Finance
Yahoo FinanceVanguard Capital Management (ANIK) discloses 4.95% beneficial stake in Anika Therapeutics - Stock Titan
2 d sedanVanguard Capital Management (ANIK) discloses 4.95% beneficial stake in Anika Therapeutics Stock Titan
Stock TitanAnika Therapeutics (ANIK) Stock Jumps As Profit Returns Sharpen Margin Focus - simplywall.st
2 d sedanAnika Therapeutics (ANIK) Stock Jumps As Profit Returns Sharpen Margin Focus simplywall.st
simplywall.stAnika Therapeutics (ANIK) Surges 7.8%: Technical Breakout in Motion - MFI Overbought - dars.gov.et
3 d sedanAnika Therapeutics (ANIK) Surges 7.8%: Technical Breakout in Motion - MFI Overbought dars.gov.et
dars.gov.etANIK|Anika Therapeutics Inc|Price:18.780|Chg%:+0.710 - TradingKey
3 d sedanANIK|Anika Therapeutics Inc|Price:18.780|Chg%:+0.710 TradingKey
TradingKeyAnika Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ANIK) 2026-07-29 - Seeking Alpha
4 d sedanAnika Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ANIK) 2026-07-29 Seeking Alpha
Seeking AlphaAnika Therapeutics Q2 revenue rises 16% to $32.6 million - quiverquant.com
4 d sedanAnika Therapeutics Q2 revenue rises 16% to $32.6 million quiverquant.com
quiverquant.comAnika's International Revenue Sets Record at $12.6M in Q2 - Stock Titan
4 d sedanAnika's International Revenue Sets Record at $12.6M in Q2 Stock Titan
Stock TitanINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
2025-09-13INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK PR Newswire NEW YORK, Sept. 13, 2025 NEW YORK , Sept. 13, 2025 /PRNewswire/ -- P
Anika TherapeuticsPR NewswireAnika to Participate in 2020 UBS Virtual Global Healthcare Conference
2020-05-12Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Offi
Anika Therapeutics IncBusiness WireAnika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
2020-04-27Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t
Anika Therapeutics IncBusiness WireAnika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7
2020-04-23Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its inv
Anika Therapeutics IncBusiness WireAnika Appoints David Colleran as General Counsel
2020-03-04Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t
Anika Therapeutics IncBusiness WireAnika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
2020-02-06Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the close of the market on Thursday, February 20,
Anika Therapeutics IncBusiness WireCORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
2020-02-06First paragraph, first sentence should read: Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the c
Anika Therapeutics IncBusiness Wire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.